₹427.20
+3.20 (+0.75%)
As of 18 Sept 2026, Aarti Drugs Ltd share price is ₹427.20. The stock opened at ₹427.20 and had closed at ₹424.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹318.60 and a high of ₹534.15. In terms of performance, Aarti Drugs Ltd share price has increased by 24.32% over the past six months and has decreased by 19.23% over the last year.
AARTIDRUGS Stock Price Chart
Aarti Drugs Ltd Overview
Market cap₹3,899 Crs
Volume7,343
Prev. Close₹424.00
Year range₹318.60 - ₹534.15
ISININE767A01016
About AARTIDRUGS
Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.
Aarti Drugs Ltd Historical Performance
1 Month Return3.31%
6 Month Return25.26%
3 Year Return-27.43%
3 Month Return14.01%
1 Year Return-16.97%
5 Year Return-32.74%
Aarti Drugs Ltd Fundamentals
ROCE(TTM)11.38%
P/E Ratio (TTM)22.75
P/B Ratio2.78
Debt to Equity0.30
ROE12.05%
EPS (TTM)18.95
Dividend Yield0.47%
Book Value153.92
Profit Margin7.31%
Operating Margin9.72%
Aarti Drugs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,262.98 | 2,187.22 | 2,271.09 | 2,500.20 | 2,255.94 |
| EBITDA | 263.33 | 276.22 | 270.31 | 284.63 | 322.95 |
| Net Profit | 169.22 | 157.31 | 141.88 | 152.81 | 195.00 |
| EPS | 18.54 | 17.18 | 15.35 | 16.50 | 21.04 |
Aarti Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 412.43 |
| Resistance 1 (R1) | 433.33 |
| Pivot Point | 421.77 |
Aarti Drugs Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 09-Feb-2026 | 03-Feb-2026 | 09-Feb-2026 | Interim | ₹2.00 |
| 04-Feb-2025 | 29-Jan-2025 | 04-Feb-2025 | Interim | ₹1.00 |
| 06-Feb-2024 | 24-Jan-2024 | 06-Feb-2024 | Interim | ₹1.00 |
| 08-Feb-2023 | 27-Jan-2023 | 08-Feb-2023 | Interim | ₹1.00 |
| 09-Feb-2022 | 31-Jan-2022 | 10-Feb-2022 | Interim | ₹1.00 |
AARTIDRUGS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Prakash M Patil | CMD & Executive Directorector |
| Rashesh C Gogri | Managing Director |
| Harshit M Savla | Managing Director |
Aarti Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aarti Drugs Ltd today is ₹427.20 on NSE and ₹427.20 on BSE.
- The 52-week high of Aarti Drugs Ltd is ₹534.15, while the 52-week low is ₹318.60.
- The current market capitalisation of Aarti Drugs Ltd is approximately ₹3,899 crore.
- The P/E (Price-to-Earnings) ratio of Aarti Drugs Ltd is 16.21. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aarti Drugs Ltd is 2.24. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aarti Drugs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AARTIDRUGS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aarti Drugs Ltd has delivered a return of approximately -27.43%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aarti Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 54.43% promoters, -8.56% FIIs, 10.29% DIIs, and 24.12% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
